A pooled analysis of relapsed/refractory diffuse large B-cell lymphoma patients treated with the duel PI3K and HDAC inhibitor fimepinostat (CUDC-907), including patients with MYC-altered disease Meeting Abstract
| Authors: | Landsburg, D. J.; Ramchandren, R.; Lugtenburg, P. J.; Kelly, K. R.; Younes, A.; Gharavi, R.; Tuck, D. P.; Barta, S. K. |
| Abstract Title: | A pooled analysis of relapsed/refractory diffuse large B-cell lymphoma patients treated with the duel PI3K and HDAC inhibitor fimepinostat (CUDC-907), including patients with MYC-altered disease |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454842803206 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-112527 |
| Notes: | Meeting Abstract: 4184 -- Source: Wos |
